Joint effect of urinary total arsenic level and VEGF-A genetic polymorphisms on the recurrence of renal cell carcinoma

Shu Mei Yang, Chao Yuan Huang, Horng Sheng Shiue, Shu Pin Huang, Yeong Shiau Pu, Wei Jen Chen, Ying-Chin Lin, Yu Mei Hsueh

研究成果: 雜誌貢獻文章

7 引文 (Scopus)

摘要

The results of our previous study suggested that high urinary total arsenic levels were associated with an increased risk of renal cell carcinoma (RCC). Germline genetic polymorphisms might also affect cancer risk and clinical outcomes. Vascular endothelial growth factor (VEGF) plays an important role in vasculogenesis and angiogenesis, but the combined effect of these factors on RCC remains unclear. In this study, we explored the association between the VEGFA -2578C>A, -1498T>C, -1154G>A, -634G>C, and +936C>T gene polymorphisms and RCC. We also evaluated the combined effects of the VEGF-A haplotypes and urinary total arsenic levels on the prognosis of RCC. This case-control study was conducted with 191 RCC patients who were diagnosed with renal tumors on the basis of image-guided biopsy or surgical resections. An additional 376 age- And gender-matched controls were recruited. Concentrations of urinary arsenic species were determined by a high performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Genotyping was investigated using fluorescent-based TaqMan allelic discrimination. We observed no significant associations between VEGF-A haplotypes and RCC risk. However, the VEGF-A ACGG haplotype from VEGF-A -2578, -1498, -1154, and -634 was significantly associated with an increased recurrence of RCC (OR = 3.34, 95% CI = 1.03-10.91). Urinary total arsenic level was significantly associated with the risk of RCC in a dose-response manner, but it was not related to the recurrence of RCC. The combination of high urinary total arsenic level and VEGF-A risk haplotypes affected the OR of RCC recurrence in a dose-response manner. This is the first study to show that joint effect of high urinary total arsenic and VEGF-A risk haplotypes may influence the risk of RCC recurrence in humans who live in an area without obvious arsenic exposure.
原文英語
文章編號e0145410
期刊PLoS One
10
發行號12
DOIs
出版狀態已發佈 - 十二月 1 2015

指紋

vascular endothelial growth factor A
Arsenic
Genetic Polymorphisms
kidney cells
arsenic
Polymorphism
Renal Cell Carcinoma
Vascular Endothelial Growth Factor A
carcinoma
Cells
genetic polymorphism
Recurrence
Haplotypes
haplotypes
Atomic absorption spectrometry
Biopsy
dose response
High performance liquid chromatography
Hydrides
Image-Guided Biopsy

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

引用此文

Joint effect of urinary total arsenic level and VEGF-A genetic polymorphisms on the recurrence of renal cell carcinoma. / Yang, Shu Mei; Huang, Chao Yuan; Shiue, Horng Sheng; Huang, Shu Pin; Pu, Yeong Shiau; Chen, Wei Jen; Lin, Ying-Chin; Hsueh, Yu Mei.

於: PLoS One, 卷 10, 編號 12, e0145410, 01.12.2015.

研究成果: 雜誌貢獻文章

Yang, Shu Mei ; Huang, Chao Yuan ; Shiue, Horng Sheng ; Huang, Shu Pin ; Pu, Yeong Shiau ; Chen, Wei Jen ; Lin, Ying-Chin ; Hsueh, Yu Mei. / Joint effect of urinary total arsenic level and VEGF-A genetic polymorphisms on the recurrence of renal cell carcinoma. 於: PLoS One. 2015 ; 卷 10, 編號 12.
@article{0a3ffa9a68ad42f596e1f39703b813d6,
title = "Joint effect of urinary total arsenic level and VEGF-A genetic polymorphisms on the recurrence of renal cell carcinoma",
abstract = "The results of our previous study suggested that high urinary total arsenic levels were associated with an increased risk of renal cell carcinoma (RCC). Germline genetic polymorphisms might also affect cancer risk and clinical outcomes. Vascular endothelial growth factor (VEGF) plays an important role in vasculogenesis and angiogenesis, but the combined effect of these factors on RCC remains unclear. In this study, we explored the association between the VEGFA -2578C>A, -1498T>C, -1154G>A, -634G>C, and +936C>T gene polymorphisms and RCC. We also evaluated the combined effects of the VEGF-A haplotypes and urinary total arsenic levels on the prognosis of RCC. This case-control study was conducted with 191 RCC patients who were diagnosed with renal tumors on the basis of image-guided biopsy or surgical resections. An additional 376 age- And gender-matched controls were recruited. Concentrations of urinary arsenic species were determined by a high performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Genotyping was investigated using fluorescent-based TaqMan allelic discrimination. We observed no significant associations between VEGF-A haplotypes and RCC risk. However, the VEGF-A ACGG haplotype from VEGF-A -2578, -1498, -1154, and -634 was significantly associated with an increased recurrence of RCC (OR = 3.34, 95{\%} CI = 1.03-10.91). Urinary total arsenic level was significantly associated with the risk of RCC in a dose-response manner, but it was not related to the recurrence of RCC. The combination of high urinary total arsenic level and VEGF-A risk haplotypes affected the OR of RCC recurrence in a dose-response manner. This is the first study to show that joint effect of high urinary total arsenic and VEGF-A risk haplotypes may influence the risk of RCC recurrence in humans who live in an area without obvious arsenic exposure.",
author = "Yang, {Shu Mei} and Huang, {Chao Yuan} and Shiue, {Horng Sheng} and Huang, {Shu Pin} and Pu, {Yeong Shiau} and Chen, {Wei Jen} and Ying-Chin Lin and Hsueh, {Yu Mei}",
year = "2015",
month = "12",
day = "1",
doi = "10.1371/journal.pone.0145410",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - Joint effect of urinary total arsenic level and VEGF-A genetic polymorphisms on the recurrence of renal cell carcinoma

AU - Yang, Shu Mei

AU - Huang, Chao Yuan

AU - Shiue, Horng Sheng

AU - Huang, Shu Pin

AU - Pu, Yeong Shiau

AU - Chen, Wei Jen

AU - Lin, Ying-Chin

AU - Hsueh, Yu Mei

PY - 2015/12/1

Y1 - 2015/12/1

N2 - The results of our previous study suggested that high urinary total arsenic levels were associated with an increased risk of renal cell carcinoma (RCC). Germline genetic polymorphisms might also affect cancer risk and clinical outcomes. Vascular endothelial growth factor (VEGF) plays an important role in vasculogenesis and angiogenesis, but the combined effect of these factors on RCC remains unclear. In this study, we explored the association between the VEGFA -2578C>A, -1498T>C, -1154G>A, -634G>C, and +936C>T gene polymorphisms and RCC. We also evaluated the combined effects of the VEGF-A haplotypes and urinary total arsenic levels on the prognosis of RCC. This case-control study was conducted with 191 RCC patients who were diagnosed with renal tumors on the basis of image-guided biopsy or surgical resections. An additional 376 age- And gender-matched controls were recruited. Concentrations of urinary arsenic species were determined by a high performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Genotyping was investigated using fluorescent-based TaqMan allelic discrimination. We observed no significant associations between VEGF-A haplotypes and RCC risk. However, the VEGF-A ACGG haplotype from VEGF-A -2578, -1498, -1154, and -634 was significantly associated with an increased recurrence of RCC (OR = 3.34, 95% CI = 1.03-10.91). Urinary total arsenic level was significantly associated with the risk of RCC in a dose-response manner, but it was not related to the recurrence of RCC. The combination of high urinary total arsenic level and VEGF-A risk haplotypes affected the OR of RCC recurrence in a dose-response manner. This is the first study to show that joint effect of high urinary total arsenic and VEGF-A risk haplotypes may influence the risk of RCC recurrence in humans who live in an area without obvious arsenic exposure.

AB - The results of our previous study suggested that high urinary total arsenic levels were associated with an increased risk of renal cell carcinoma (RCC). Germline genetic polymorphisms might also affect cancer risk and clinical outcomes. Vascular endothelial growth factor (VEGF) plays an important role in vasculogenesis and angiogenesis, but the combined effect of these factors on RCC remains unclear. In this study, we explored the association between the VEGFA -2578C>A, -1498T>C, -1154G>A, -634G>C, and +936C>T gene polymorphisms and RCC. We also evaluated the combined effects of the VEGF-A haplotypes and urinary total arsenic levels on the prognosis of RCC. This case-control study was conducted with 191 RCC patients who were diagnosed with renal tumors on the basis of image-guided biopsy or surgical resections. An additional 376 age- And gender-matched controls were recruited. Concentrations of urinary arsenic species were determined by a high performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Genotyping was investigated using fluorescent-based TaqMan allelic discrimination. We observed no significant associations between VEGF-A haplotypes and RCC risk. However, the VEGF-A ACGG haplotype from VEGF-A -2578, -1498, -1154, and -634 was significantly associated with an increased recurrence of RCC (OR = 3.34, 95% CI = 1.03-10.91). Urinary total arsenic level was significantly associated with the risk of RCC in a dose-response manner, but it was not related to the recurrence of RCC. The combination of high urinary total arsenic level and VEGF-A risk haplotypes affected the OR of RCC recurrence in a dose-response manner. This is the first study to show that joint effect of high urinary total arsenic and VEGF-A risk haplotypes may influence the risk of RCC recurrence in humans who live in an area without obvious arsenic exposure.

UR - http://www.scopus.com/inward/record.url?scp=84956909918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956909918&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0145410

DO - 10.1371/journal.pone.0145410

M3 - Article

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e0145410

ER -